Ashish Sharma
@aks-kidneydoc.bsky.social
Kidney Doctor | NSW Health 🇦🇺 |
PhD @UniMelb @TheRMH | Renal Bone Disease | @AKS_KidneyDoc on X
⭐ 🏏 Cricket lover
⭐ 📷 Photography enthusiast
⭐ 🤝 People & meaningful moments
PhD @UniMelb @TheRMH | Renal Bone Disease | @AKS_KidneyDoc on X
⭐ 🏏 Cricket lover
⭐ 📷 Photography enthusiast
⭐ 🤝 People & meaningful moments
Reposted by Ashish Sharma
And the causes of death are heart failure, sudden death, infections- how would fish oil impact those in such a huge way?
It is all a bit puzzling
See @nephroseeker.medsky.social beautiful VA till then
#KidneyWk
It is all a bit puzzling
See @nephroseeker.medsky.social beautiful VA till then
#KidneyWk
November 9, 2025 at 11:49 AM
And the causes of death are heart failure, sudden death, infections- how would fish oil impact those in such a huge way?
It is all a bit puzzling
See @nephroseeker.medsky.social beautiful VA till then
#KidneyWk
It is all a bit puzzling
See @nephroseeker.medsky.social beautiful VA till then
#KidneyWk
Reposted by Ashish Sharma
Reposted by Ashish Sharma
And in the evening
- a CAR T in refractory SLE
- a PKD trial
- increasing PD in Vets
- Povetacicept in IgA
- TESTING Longterm term data
- what do the AHA/ACC BP guidelines mean?
#KidneyWk
- a CAR T in refractory SLE
- a PKD trial
- increasing PD in Vets
- Povetacicept in IgA
- TESTING Longterm term data
- what do the AHA/ACC BP guidelines mean?
#KidneyWk
November 8, 2025 at 2:11 PM
And in the evening
- a CAR T in refractory SLE
- a PKD trial
- increasing PD in Vets
- Povetacicept in IgA
- TESTING Longterm term data
- what do the AHA/ACC BP guidelines mean?
#KidneyWk
- a CAR T in refractory SLE
- a PKD trial
- increasing PD in Vets
- Povetacicept in IgA
- TESTING Longterm term data
- what do the AHA/ACC BP guidelines mean?
#KidneyWk
Reposted by Ashish Sharma
The oral sema results are interesting
Difficult to comment indirectly, but seems less impressive than injectable sema?
Lot of kidney and HF events and favourable point estimates but not a huge effect
#ACC25
Difficult to comment indirectly, but seems less impressive than injectable sema?
Lot of kidney and HF events and favourable point estimates but not a huge effect
#ACC25
March 29, 2025 at 9:51 PM
The oral sema results are interesting
Difficult to comment indirectly, but seems less impressive than injectable sema?
Lot of kidney and HF events and favourable point estimates but not a huge effect
#ACC25
Difficult to comment indirectly, but seems less impressive than injectable sema?
Lot of kidney and HF events and favourable point estimates but not a huge effect
#ACC25
Reposted by Ashish Sharma
Although I suppose that the newly published meta-analysis is the counterpoint.
March 29, 2025 at 10:24 PM
Although I suppose that the newly published meta-analysis is the counterpoint.
Reposted by Ashish Sharma
Also note two large RCTs ongoing - or about to start - in France: bsky.app/profile/dgue...
Hi Swapnil, as you may know 2 large RCTs, DAPA-PKD & STOP-PKD have secured academic funding to evaluate the use of SGLT2i in ADPKD. They are set to launch in 2026.
Upon completion, both trials will combine their datasets in a pooled analysis, called FLOZIN-PKD. Hope you like the name 😉
Upon completion, both trials will combine their datasets in a pooled analysis, called FLOZIN-PKD. Hope you like the name 😉
March 23, 2025 at 1:46 AM
Also note two large RCTs ongoing - or about to start - in France: bsky.app/profile/dgue...
Reposted by Ashish Sharma
We also recently transitioned a pt to both - incremental HDF 💧💦 Some are very CONVINCEd in our dept but we may INCH closer to finding an answer #AKTN aktn.org.au/inch-hd/ pubmed.ncbi.nlm.nih.gov/36938090/ @sarahkmels.bsky.social @nephmadness.bsky.social
INCH-HD - Australasian Kidney Trials Network (AKTN)
The INCremental dialysis to improve Health outcomes in people starting Haemodialysis (INCH-HD) study: a randomised controlled trial
aktn.org.au
March 21, 2025 at 9:07 PM
We also recently transitioned a pt to both - incremental HDF 💧💦 Some are very CONVINCEd in our dept but we may INCH closer to finding an answer #AKTN aktn.org.au/inch-hd/ pubmed.ncbi.nlm.nih.gov/36938090/ @sarahkmels.bsky.social @nephmadness.bsky.social